Develop creative neurotechnology for improving the health and quality of life of individuals with neurological conditions. While our present focus is epilepsy, our vision extends to assisting with a multitude of neurological disorders. Epilepsy is a chronic disease characterized by seizures of enhanced and synchronous electrical activity in neuronal networks in the brain, affecting 1% of the world's population. Importantly, around 30% of the patients do not respond to current medications and their seizures cannot be predicted Our team developed novel data analysis and machine learning solutions that use non-invasive brain monitoring to forecast upcoming seizures an hour in advance. Our team's goal is turning epilepsy into a disorder that does not limit the ability of patients to enjoy common activities and is no longer life-threatening.
| Website | https://www.neuro-help.com/ |
| Employees | 12 (9 on RocketReach) |
| Founded | 2020 |
| Phone | +1 212-279-1300 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Epilepsy Treatment, Neurological Technology, Seizure Management, Epilepsy Care, Brain Health, Seizure Detection, Neurological Disorders, Brain Stimulation, Neural Rehabilitation, Neurological Devices, Brain Health Solutions, Cognitive Enhancement, Neurological Care, Brain Computer Interface, Health Technology, Medical Technology, Neurological Research, Mental Health |
| Competitors | BrainCo_Tech, MindMaze, EMOTIV, Magstim, Neurable, Cognixion, NeuroSky, BrainTap Technologies, Sync Think, Inc., OpenBCI +17 more (view full list) |
Looking for a particular NeuroHelp employee's phone or email?
Shay Ben-Sasson is the CEO of NeuroHelp.
9 people are employed at NeuroHelp.